Max Healthcare Institute Ltd Stock Price Today (NSE: MAXHEALTH)

Max Healthcare Institute Ltd

MAXHEALTHHospital
948.70+10.25 (+1.09%)
Market Closed

Fundamental Score

...

Max Healthcare Institute Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Max Healthcare Institute Ltd share price today is 948.70, up +1.09% on NSE/BSE as of 2 June 2026. Max Healthcare Institute Ltd (MAXHEALTH) is a Large-cap company in the Hospital sector with a market capitalisation of 1.09L (Cr). The 52-week high for MAXHEALTH share price is 1314.30 and the 52-week low is 903.00. At a P/E ratio of 77.65x, MAXHEALTH is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 12.72% and a debt-to-equity ratio of 0.33.

Max Healthcare Institute Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
1111.00
Low
934.95
Volume
24.2L
Change
-1.62%

Max Healthcare Institute Ltd share price chart: -1.62% return over the past month. 52-week high ₹1314.30, 52-week low ₹903.00.

Max Healthcare Institute Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
995.001000.00979.80993.4526.22L (Cr)
1000.901000.90987.15993.9525.15L (Cr)
1020.051029.45994.001000.8538.47L (Cr)
1068.251068.251011.001023.25117.11L (Cr)
1086.901111.001079.051091.1027.64L (Cr)
1060.051080.001052.751075.7017.68L (Cr)
1061.601080.001054.651068.7521.03L (Cr)
1040.001063.001024.301058.5515.58L (Cr)
1049.551059.901042.401050.1014.71L (Cr)
1025.201057.701025.151049.5518.22L (Cr)

Max Healthcare Institute Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
993.051111.00979.80993.45+0.04%
966.201029.10903.00993.05+2.78%
1056.501088.40937.30962.30-8.92%
980.001112.55933.801091.95+11.42%
1048.201064.40940.00956.80-8.72%
1164.001167.401024.901045.10-10.21%
1146.701185.401075.101162.80+1.40%
1119.701221.901060.001147.80+2.51%
1154.301189.001107.001114.70-3.43%
1245.001301.701147.601154.30-7.29%
1285.001314.301201.001246.00-3.04%
1129.501296.801122.401276.00+12.97%

Returns & Performance

Poor

Return on Equity (ROE)

12.72%

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

14.88%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

25.31%

Average operating profit margin over 5 years

Dividend Yield

0.13%

Annual dividend as % of current share price

Max Healthcare Institute Ltd Valuation Check

Poor

Price to Earnings (P/E)

77.65x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

52.84x

Average P/E of all peers in this sector

Market-cap Classification
Large-cap
Established & liquid; typically steadier returns.

Shareholding Pattern

Excellent

Promoter Holding

23.74%

% shares held by company founders/management

Excellent

FII Holding

51.80%

% shares held by foreign institutional investors

Excellent

DII Holding

20.03%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Excellent

Profit Growth (Quarterly YoY)

74.34%

Net profit growth vs same quarter last year

Excellent

Revenue Growth (Quarterly YoY)

25.07%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

46.01%

Compounded annual revenue growth over 5 years

Excellent

EPS Growth (5-Year CAGR)

60.31%

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

80.50%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.33x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

8.54x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

1.99K (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Max Healthcare Institute Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of MAXHEALTH across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Strong Operating Margins (25.31%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Robust Profit Growth (74.34%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture.

Strong Revenue Growth (25.07%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (46.01% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Excellent EPS Growth (60.31% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential.

Strong Profit Growth Track Record (80.50% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Strong Interest Coverage (8.54x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Strong Cash Generation (₹1988.23 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Strong Institutional Confidence (FII+DII: 71.83%)

Observation: Significant professional investor participation.

Analysis: High institutional holding often signals thorough due diligence.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

2 factors identified

Premium Valuation Risk (P/E: 77.65x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

Low Promoter Commitment (23.74%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

Max Healthcare Institute Ltd vs Hospital Peers

Peer Comparison - Hospital

Compare Max Healthcare Institute Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
69.1/100
949
₹109416.28
77.7
Average
12.72%
Average
14.88%
Average
0.3
Excellent
80.50%
Excellent
46.01%
Excellent
0.13%
50.2/100
8273
₹104825.94
62.7
Average
18.42%
Good
16.64%
Good
0.9
Good
33.72%
Excellent
14.15%
Good
0.26%
55.6/100
961
₹68301.24
67.8
Average
10.13%
Average
11.96%
Average
0.3
Excellent
70.31%
Excellent
10.93%
Good
0.11%
62.2/100
1884
₹39051.19
45.9
Average
24.22%
Excellent
20.75%
Excellent
0.6
Good
43.49%
Excellent
11.88%
Good
0.24%
15.4/100
741
₹34688.15
94.5
Average
8.26%
Poor
10.68%
Average
0.5
Excellent
-7.24%
Poor
-13.71%
Poor
0.75%
61/100
1240
₹33498.00
56.0
Average
16.48%
Good
19.74%
Good
0.3
Excellent
70.15%
Excellent
19.73%
Excellent
0.04%
45.1/100
741
₹27605.54
84.0
Average
18.48%
Good
15.00%
Good
1.4
Average
25.01%
Excellent
22.01%
Excellent
0.00%
51.2/100
480
₹16844.04
145.2
Average
4.76%
Poor
9.99%
Poor
0.5
Good
41.72%
Excellent
26.38%
Excellent
0.00%
54.6/100
1351
₹13410.38
52.8
Average
17.43%
Good
18.69%
Good
0.5
Good
33.66%
Excellent
16.08%
Excellent
0.23%
36.4/100
647
₹10474.40
296.2
Average
5.14%
Poor
8.56%
Poor
1.9
Average
19.34%
Excellent
15.22%
Excellent
0.00%
62.9/100
1329
₹9678.17
48.8
Average
14.95%
Average
17.95%
Good
0.3
Excellent
43.62%
Excellent
22.20%
Excellent
0.07%

Max Healthcare Institute Ltd PE Ratio History

Historical price-to-earnings ratio for MAXHEALTH — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 202511.01₹1045.1094.9x
FY 202410.84₹1128.15104.1x
FY 202311.36₹686.2560.4x
FY 20226.24₹439.5570.4x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Max Healthcare Institute Ltd Dividend History

Annual cash dividends paid by MAXHEALTH — dividend yield 0.13%

Financial YearDividends Paid (₹ Cr)
FY 2025145.58 Cr
FY 202497.01 Cr

Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.

Max Healthcare Institute Ltd Quarterly Performance

Latest quarterly metrics for MAXHEALTH — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

25.07%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

74.34%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

46.01%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

80.50%

Compounded annual net profit growth over 5 years

Max Healthcare Institute Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for MAXHEALTH — calculated from daily price history

45RSI 14
Neutral — RSI 45

Momentum is balanced — neither overbought nor oversold.

SMA 50
997
▼ Price below SMA 50 — Short-term bearish
SMA 200
1085
▼ Price below SMA 200 — Long-term downtrend
30-Day Avg Volume
2330K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Max Healthcare Institute Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Max Healthcare Institute Ltd (MAXHEALTH) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Max Healthcare Institute Ltd

About MAXHEALTH (Max Healthcare Institute Ltd)

Max Healthcare Institute Ltd is a prominent healthcare provider in India, distinguished by its commitment to delivering advanced medical care across a wide spectrum of specialties.... Housing state-of-the-art facilities and a team of highly skilled medical professionals, Max Healthcare stands as a beacon of hope and healing for patients seeking world-class treatment. Its comprehensive services encompass both inpatient and outpatient care, ensuring that individuals receive personalized attention and the best possible outcomes. Dedicated to innovation and patient-centricity, Max Healthcare strives to redefine healthcare standards in India and beyond, offering a holistic approach that addresses the physical, emotional, and mental well-being of its patients. The hospital's expansive range of services extends to critical and complex medical areas, including cardiac care, bone and joint replacements, cancer treatment, and neurological disorders. The institute provides specialized care in other fields, like kidney ailments, digestive system issues, and disorders of the respiratory system, reflecting its dedication to addressing diverse healthcare requirements. Max Healthcare's expertise also covers women's health, children's health, and the intricate domain of organ transplantation, signifying its capability to manage life-altering medical challenges. Each department integrates cutting-edge technology with evidence-based practices, establishing Max Healthcare as a preferred choice for patients seeking specialized and reliable medical intervention. Beyond its advanced clinical services, Max Healthcare also provides alternative models to deliver care. It offers Max@Home, a service designed to extend quality healthcare beyond the confines of the hospital. This program offers medical attention in the comfort of a patient's home, catering to individuals who require ongoing care, elderly patients, or those with mobility challenges. This initiative underscores Max Healthcare's dedication to providing easily accessible, patient-focused healthcare solutions, bridging the gap between hospital-based treatment and continuing well-being.

Company Details

Symbol:MAXHEALTH
Industry:Hospital
Sector:Hospital

Key Leadership

Mr. Abhay Soi
Executive Chairman & MD
Mr. Yogesh Kumar Sareen
Senior Director & CFO
Mr. Dhiraj Aroraa
Senior VP, Company Secretary & Compliance Officer

Corporate Events

Upcoming
Earnings Date
Recent
Ex-Dividend Date

MAXHEALTH Share Price: Frequently Asked Questions

What is the current share price of Max Healthcare Institute Ltd?

Max Healthcare Institute Ltd (MAXHEALTH) trades at ₹948.70 on NSE and BSE. Market cap ₹1.09L (Cr). Educational data only.

What is the P/E ratio of Max Healthcare Institute Ltd?

Max Healthcare Institute Ltd has a P/E of 77.65x vs industry average 52.84x.

What is the Bull Run score for Max Healthcare Institute Ltd?

Max Healthcare Institute Ltd has a Bull Run score of 69.1/100 based on 25+ financial parameters.

Does Max Healthcare Institute Ltd pay dividends?

Max Healthcare Institute Ltd has a dividend yield of 0.13%. Past dividends don't guarantee future payments.

What is the ROE of Max Healthcare Institute Ltd?

Max Healthcare Institute Ltd has ROE of 12.72%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Max Healthcare Institute Ltd?

Max Healthcare Institute Ltd has debt-to-equity of 0.33.

Is Max Healthcare Institute Ltd a good investment?

Bull Run gives Max Healthcare Institute Ltd a score of 69.1/100. This is not investment advice — consult a SEBI-registered advisor.